Perioperative Intervention by β-Blockade and NF-κB Suppression Reduces the Recurrence Risk of Endometriosis in Mice Due to Incomplete Excision
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Despite the demonstrated efficacy of surgical treatment of endometriosis, recurrence after surgery still remains a formidable challenge. Surgery, especially when performed repeatedly, decreases ovarian reserve. Clearly, control of recurrence is an unmet medical need. So far nearly all efforts to control recurrence have been devoted to the identification of risk factors, biomarkers, and postoperative medication. One area that has been completely overlooked is the possibility of perioperative intervention. In this study, we tested the hypothesis that perioperative use of a nonspecific β-blocker and/or a nuclear factor-κB (NF-κB) inhibitor can retard the growth of residual endometriotic lesions that are left intact in the primary surgery. We established a mouse model of recurrence due to incomplete lesion removal by deliberately leaving residual lesions intact in the primary excision surgery. One hour before and 24 hours after the surgery, mice were either untreated or treated with andrographolide, propranolol, or both. Two weeks after the primary surgery, all mice were sacrificed and all lesions were excised and evaluated for immunohistochemistry analysis. We found that perioperative use of andrographolide and/or propranolol significantly decelerated the growth of residual lesions that were intentionally left out during the primary surgery. The perioperative intervention also significantly attenuated the generalized hyperalgesia resulting from the presence of residual lesions. It also inhibited the activation of the adrenergic receptor β2 signaling, resulting in reduced angiogenesis, epithelial-mesenchymal transition, fibroblast-to-myofibroblast transdifferentiation as well as NF-κB suppression and progesterone receptor isoform B induction. These data strongly suggest that perioperative use of β-blockers and/or NF-κB inhibitors may reduce the risk of recurrence in endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beta-blockers, primarily used in cardiovascular conditions, have been investigated for their potential to alleviate pain and inflammation in endometriosis by modulating sympathetic nervous system activity and reducing pro-inflammatory cytokine release [44,45].”
From Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms (2025) · cites this paper as [45]
In the citing paper
“Among these, antiplatelet agents, beta-blockers, statins, and metformin have shown promise.”
From Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms (2025) · cites this paper as [45]
In the citing paper
“it raises a tantalizing possibility that perioperative intervention could reduce the risk of adenomyosis, as in the case of a reduction in recurrence risk in endometriosis [100].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [100]
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
The 1996 Guide for the Care and Use of Laboratory Animals
Clark, J. D., Gebhart, G. F., Gonder, J. C., Keeling, M. E., & Kohn, D. F. (1997) · ILAR Journal · doi:10.1093/ilar.38.1.41 · Cited by 4,417
The stress response to trauma and surgery
Desborough, J. P. (2000) · British Journal of Anaesthesia · doi:10.1093/bja/85.1.109 · Cited by 2,296
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
Endometriosis and infertility: pathophysiology and management
de Ziegler, D., Borghese, B., & Chapron, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60490-4 · Cited by 843
Recurrence of endometriosis and its control
Guo, S.-W. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp007 · Cited by 719
Self-citationPerioperative events influence cancer recurrence risk after surgery
Hiller, J. G., Perry, N. J., Poulogiannis, G., Riedel, B., & Sloan, E. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.194 · Cited by 556
Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK
Hadfield, R., Mardon, H., Barlow, D., & Kennedy, S. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019270 · Cited by 517
Cited by
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
Guo, S.-W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020485 · Cited by 165
“cell-mediated immunity that promotes the survival of endometrial cells dispersed and displaced by the procedure, it raises a tantalizing possibility that perioperative intervention could reduce the risk of adenomyosis, as in the case of a reduction in recurrence risk in endometriosis [100].”
BackgroundSelf-citationAn Update on the Multifaceted Role of NF-kappaB in Endometriosis
Liu, Y., Wang, J., & Zhang, X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72707 · Cited by 112
“Preclinical in vivo and/or in vitro experiments have discovered a large number of drugs that inhibit NF-κB signaling and thus alleviate the development of endometriosis (Table 1) [13, 14, 16, 18, 19, 36, 46, 67, 75, 87, 88, 91-119].”
BackgroundEndometriosis and cardiovascular disease
Marchandot, B., Curtiaud, A., Matsushita, K., Trimaille, A., Host, A., Faller, É., Garbin, O., Akladios, C. Y., Jesel, L., & Morel, O. (2022) · European Heart Journal Open · doi:10.1093/ehjopen/oeac001 · Cited by 85
“127 endometriosis significantly decelerated the growth of residual lesions that were intentionally left out during the primary surgery.”
BackgroundThe role of pharmacotherapy in the treatment of endometriosis across the lifespan
Schwartz, K. M., Llarena, N. C., Rehmer, J. M., Richards, E. G., & Falcone, T. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1738386 · Cited by 60
“In one study, a mouse model was developed to compare the size of endometriosis lesions intentionally left behind post-surgically in a control group compared to the group treated with immune modulators (Nf-kappa B inhibitors or a beta-blocker) in the perioperative period; in the groups treated with either beta-blockers…”
BackgroundHao, M., Liu, X., & Guo, S. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.07.023 · Cited by 42
Self-citation
Metadata
- Authors
- Long, Q., Zheng, H., Liu, X., & Guo, S.-W.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Guo, Sun-Wei
- Venue
- Reproductive Sciences
- Published
- 2019-05
- Volume
- 26
- Issue
- 5
- Pages
- 697-708
- ISSN
- 1933-7191 (ISSN-L)
- 1933-7205
- OpenAlex
- W2912826150
- Cited by
- 16
- References
- 91
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2022: 6 · 2021: 1 · 2020: 4
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Reproductive Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81471434)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- endometriosis, recurrence, perioperative interventions, beta-blockers, propranolol, andrographolide, NF-κB inhibition, incomplete excision, angiogenesis, epithelial-mesenchymal transition, fibroblast-to-myofibroblast transdifferentiation, hyperalgesia, mouse model
- MeSH terms
- Adrenergic beta-Antagonists, Animals, Diterpenes, Endometriosis, Female, Mice, Inbred BALB C, Neovascularization, Pathologic, Propranolol, Risk Factors, NF-kappa B, Secondary Prevention, Epithelial-Mesenchymal Transition, Perioperative Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perioperative Intervention by β-Blockade and NF-κB Suppression Reduces the Recurrence Risk of Endometriosis in Mice Due to Incomplete Excision. https://app.cochat.ai/papers/10.1177/1933719119828066
- The paper
- Long, Q., Zheng, H., Liu, X., & Guo, S.-W. (2019). Perioperative Intervention by β-Blockade and NF-κB Suppression Reduces the Recurrence Risk of Endometriosis in Mice Due to Incomplete Excision. Reproductive Sciences. https://doi.org/10.1177/1933719119828066
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.